Science 3 min read

Young Blood Transfusion As Anti-Ageing Remedy Is A Scam, FDA Warns

A recent FDA statement has warned the public about the use of the young blood transfusion process. According to the government body, the service could be highly dangerous.

This FDA statement could significantly damage the young blood transfusion business ¦ Pixabay

This FDA statement could significantly damage the "young blood" transfusion business ¦ Pixabay

Since the beginning of time, humans have wanted to be immortal. Unsurprisingly, this quest has led to the most unusual anti-aging remedies. Whether its the philosopher’s stone or Google Calico, longevity researches have always captured our imagination.

The most hyped anti-aging remedy in modern times may be the young blood transfusion.

The belief is that injecting an old person with the blood of a younger and healthier person not only alleviates health issues, but it could also restore youth. Yes, something like an elixir of life.

As creepy as it sounds, several companies in the United States and across the world are already offering a young blood transfusion service. An example of such is Ambrosia.

Founded in 2016 by Jesse Karmazin, Ambrosia transfuses the plasma of 16 to 25 years olds into older people for as much as $12,000.

While the clinic got a lot of attention for its unorthodox methods, several criticisms soon followed. Not only is the treatment controversial and expensive, but it is also unproven.

Karmazin previously reported that many of his 150 patients felt and performed better on just one treatment per year. However, he failed to publish any quantifiable measurements or statistics on their performance.

According to the U.S. Food and Drug Administration, Dr. Karmazin could be lying, and Ambrosia may be a scam.

In a statement released on Tuesday, the FDA said that young blood and plasma transfusion are useless pseudosciences that could potentially harm us.

FDA commissioner, Scott Gottlieb wrote that the treatment had not undergone the required rigorous testing. As a result, the FDA cannot guarantee its therapeutic benefits or safety.

In other words, transfusions of young plasma are not officially safe or effective.

Gottlieb also noted that the dosing is a bit worrisome. When administered in large volume, young plasma poses significant risks such as cardiovascular and respiratory issues.

Simply put, we’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies,” reads the FDA statement.

“Such treatments have no proven clinical benefits for the uses for which these clinics are advertising them and are potentially harmful.

With that said, blood and plasma transfusions have several proven medical applications. For example, plasma and red blood cell transfusion can help people with liver failure and anemia.

Sadly, mortality is not a disease that young blood and plasma transfusion can cure.

Read More: Controversial Blood Transfusion Startup to Open its First Clinic

First AI Web Content Optimization Platform Just for Writers

Found this article interesting?

Let Sumbo Bello know how much you appreciate this article by clicking the heart icon and by sharing this article on social media.


Profile Image

Sumbo Bello

Sumbo Bello is a creative writer who enjoys creating data-driven content for news sites. In his spare time, he plays basketball and listens to Coldplay.

Comment (1)
Most Recent most recent
You
  1. Profile Image
    Laura Stewart July 17 at 2:08 am GMT

    The belief is that injecting an old person with the blood of a younger and healthier person not only alleviates health issues, https://scdownloader.io but it could also restore youth.

2
share Scroll to top

Link Copied Successfully

Sign in

Sign in to access your personalized homepage, follow authors and topics you love, and clap for stories that matter to you.

Sign in with Google Sign in with Facebook

By using our site you agree to our privacy policy.